Phase 1 Peanut allergy Clinical Trials
6 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–6 of 6 trials
Recruiting
Phase 1
Safety of MOON101 for the Treatment of Peanut Allergy
Peanut allergy
Moonlight Therapeutics, Inc.40 enrolled5 locationsNCT07580898
Recruiting
Phase 1Phase 2
Study of ENP-501 in Peanut-Allergic and Non-Allergic Participants
Peanut allergy
N-Fold, LLC68 enrolled1 locationNCT07117669
Recruiting
Phase 1Phase 2
UKK-0018 as an Immunotherapeutic for Treatment of Peanut Allergies
Peanut allergyPeanut-Induced Anaphylaxis
Ukko Inc40 enrolled5 locationsNCT07349212
Recruiting
Phase 1Phase 2
Oral Immunotherapy for Peanut Allergic Patients
Peanut allergy
InnoUp Farma S.L.50 enrolled2 locationsNCT04163562
Recruiting
Phase 1Phase 2
VE416 for Treatment of Food Allergy
Peanut allergy
Massachusetts General Hospital60 enrolled1 locationNCT03936998
Completed
Phase 1
A study of the safety of a novel treatment (PVX108) for peanut allergy, conducted in peanut-allergic adults
Peanut allergy
Aravax Pty Ltd66 enrolled2 locationsACTRN12617000692336